{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:15:50Z","timestamp":1789542950530,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicol. Sci."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1093\/toxsci\/kfw218","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T15:06:25Z","timestamp":1477407985000},"page":"420-431","source":"Crossref","is-referenced-by-count":38,"title":["From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury"],"prefix":"10.1093","volume":"155","author":[{"given":"Toru","family":"Usui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Saide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kevin Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Naisbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"2017012710351435000_155.2.420.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.04048.x"},{"key":"2017012710351435000_155.2.420.2","doi-asserted-by":"publisher","DOI":"10.1021\/tx400060p"},{"key":"2017012710351435000_155.2.420.3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.3.779"},{"key":"2017012710351435000_155.2.420.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.01.027"},{"key":"2017012710351435000_155.2.420.5","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.190900"},{"key":"2017012710351435000_155.2.420.6","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3664"},{"key":"2017012710351435000_155.2.420.7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4049\/jimmunol.133.2.754","article-title":"Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens","volume":"133","author":"Jacobson","year":"1984","journal-title":"J. Immunol."},{"key":"2017012710351435000_155.2.420.8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-4-68"},{"key":"2017012710351435000_155.2.420.9","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/jac\/dkv158","article-title":"J Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases","volume":"70","author":"Lehloenya","year":"2015","journal-title":"Antimicrob Chemother"},{"key":"2017012710351435000_155.2.420.10","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-11-RG-055"},{"key":"2017012710351435000_155.2.420.11","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/954602"},{"key":"2017012710351435000_155.2.420.12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05486-11"},{"key":"2017012710351435000_155.2.420.13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/tx500285k","article-title":"Auto-oxidation of Isoniazid Leads to Isonicotinic-Lysine Adducts on Human Serum Albumin","volume":"28","author":"Meng","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"2017012710351435000_155.2.420.14","doi-asserted-by":"publisher","DOI":"10.1021\/tx300341r"},{"key":"2017012710351435000_155.2.420.15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26564"},{"key":"2017012710351435000_155.2.420.16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1021\/tx500108u","article-title":"IgG3 is the dominant subtype of anti-isoniazid antibodies in patients with isoniazid-induced liver failure","volume":"27","author":"Metushi","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"2017012710351435000_155.2.420.17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/tx500013z","article-title":"Mild isoniazid-induced liver injury in humans is associated with an increase in Th17 cells and T cells producing IL-10","volume":"27","author":"Metushi","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"2017012710351435000_155.2.420.18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901767"},{"key":"2017012710351435000_155.2.420.19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechansisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J. Clin. Exp. Hepatol"},{"key":"2017012710351435000_155.2.420.20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5533"},{"key":"2017012710351435000_155.2.420.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2108091"},{"key":"2017012710351435000_155.2.420.22","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830141004"},{"key":"2017012710351435000_155.2.420.23","doi-asserted-by":"publisher","DOI":"10.1124\/pr.113.007450"},{"key":"2017012710351435000_155.2.420.24","first-page":"327","article-title":"Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal","volume":"7","author":"Wares","year":"2003","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"2017012710351435000_155.2.420.25","first-page":"97","article-title":"Evaluation of isoniazid-associated hepatitis by immunological tests","volume":"32","author":"Warrington","year":"1978","journal-title":"Clin. Exp. Immunol."},{"key":"2017012710351435000_155.2.420.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1982.tb02521.x"},{"key":"2017012710351435000_155.2.420.27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100647"},{"key":"2017012710351435000_155.2.420.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.12.617"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/155\/2\/420\/16692495\/kfw218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T12:26:07Z","timestamp":1692534367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article-lookup\/doi\/10.1093\/toxsci\/kfw218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,25]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1093\/toxsci\/kfw218"],"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfw218","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}